Report Categories
View AllRecent Articles
View All
RNTX Rein Therapeutics shares drop 12 percent after Q4 2025 EPS misses analyst estimates by a massive margin
IBTA Ibotta reports far wider Q4 2025 loss than estimates shares dip 118 on weak quarterly results
Is ALT5 Sigma ALTS stock still a good opportunity in 2026 Q2 2025 EPS Misses Estimates
DXC Dynex Pref C reports quarterly results amid stable dividend focus shifts to portfolio quality and rate environment